132 related articles for article (PubMed ID: 4595690)
1. [Therapeutic trials in various hematosarcomas with 4-demethylepipo=dophyllotoxin-beta D thenylidene glucoside (VM 26 or EPT)].
Mathé G; Schwarzenberg L; Pouillart P; Weiner R; Oldham R; Jasmin C; Rosenfeld ; Hayat M; Schneider M; Amiel JL; Céoara B; Steresco-Musset M; de Vassal F
Nouv Presse Med; 1974 Feb; 3(8):447-51. PubMed ID: 4595690
[No Abstract] [Full Text] [Related]
2. [Acute leukemia and various hematosarcomas. Trial treatment with a second derivative of podophyllotoxin (4-demethyl-epipodophyllotoxin beta D ethylidene glucoside VP 16213 or EPE)].
Mathé G; Schwarzenberg L; Pouillart P; Weiner R; Oldham R; Jasmin C; Rosenfeld C; Hayat M; Schneider M; Amiel JL; Céoara B; Steresco-Musset M; de Vassal F
Nouv Presse Med; 1974 Mar; 3(9):521-4. PubMed ID: 4595555
[No Abstract] [Full Text] [Related]
3. Two epipodophyllotoxin derivatives, VM 26 and VP 16213, in the treatment of leukemias, hematosarcomas, and lymphomas.
Mathé G; Schwarzenberg L; Pouillart P; Oldham R; Weiner R; Jasmin C; Rosenfeld C; Hayat M; Misset JL; Musset M; Schneider M; Amiel JL; De Vassal F
Cancer; 1974 Oct; 34(4):985-92. PubMed ID: 4608026
[No Abstract] [Full Text] [Related]
4. [Combination of adriamycin, VM 26, cyclophosphamide and prednisone in the treatment of hematosarcomas].
Laurens A; Thevenot J; Charron D; Jorry F; Dumonchel P; Martola R
Ann Med Interne (Paris); 1977 May; 128(5):493-6. PubMed ID: 334012
[No Abstract] [Full Text] [Related]
5. [4-year-observation of results of VM 26 treatment of pathologic syndromes from the lymphoma malignum group].
Lawkowicz W; Polubiec A; Domańska B
Acta Haematol Pol; 1975; 6(2):143-7. PubMed ID: 1098351
[TBL] [Abstract][Full Text] [Related]
6. [Personal experience on the chemotherapy of leukemias and hematosarcomas].
Mathé G; Schneider M; Schwarzenberg L; Cattan A; Amiel JL; Schlumberger JR
Acta Genet Med Gemellol (Roma); 1968 Jan; 17(1):245-54. PubMed ID: 4874537
[No Abstract] [Full Text] [Related]
7. Experience with 4'-demethylepipodo-phyllotoxin 9-(4,6-o-2-thenylidene-beta-D-glucopyranoside); VM-26; NSC-122819 in the treatment of malignant lymphosis.
Sonntag RW; Senn HJ; Nagel G; Giger K; Alberto P
Eur J Cancer (1965); 1974 Feb; 10(2):93-8. PubMed ID: 4611772
[No Abstract] [Full Text] [Related]
8. [Mithramycin therapy of hypercalcemia in patients with neoplastic diseases].
Skovgaard M
Ugeskr Laeger; 1974 Aug; 136(32):1814-7. PubMed ID: 4277881
[No Abstract] [Full Text] [Related]
9. Vinblastine treatment of malignant lymphomas.
Klener P; Donner L; Neuwirtová R; Ort J
Neoplasma; 1971; 18(5):505-11. PubMed ID: 4940935
[No Abstract] [Full Text] [Related]
10. Initial clinical experience with vinglycinate sulfate, a molecular modification of vinblastine.
Armstrong JG; Dyke RW; Fouts PJ; Hawthorne JJ; Jansen CJ; Peabody AM
Cancer Res; 1967 Feb; 27(2):221-7. PubMed ID: 5335120
[No Abstract] [Full Text] [Related]
11. Bleomycin in the treatment of the advanced, resistant and recurrent lymphomata.
Garrett MJ; Smith JD
Ir Med J; 1976 Feb; 69(3):67-70. PubMed ID: 67107
[No Abstract] [Full Text] [Related]
12. [The role of vinblastine in the treatment of malignant lymphomas].
Eridani S; Esposito R; Ponti GB; Giangrande A
Cancro; 1968; 21():Suppl 6:102+. PubMed ID: 4906143
[No Abstract] [Full Text] [Related]
13. Clinical screening of epipodophyllotoxin VM26 in malignant lymphomas and solid tumours.
Br Med J; 1972 Jun; 2(5816):744-8. PubMed ID: 4556544
[TBL] [Abstract][Full Text] [Related]
14. Epipodophyllotoxin VP 16213 in treatment of acute leukaemias, haematosarcomas, and solid tumours.
European Organization for Research on the Treatment of Cancer, Clinical Screening Group
Br Med J; 1973 Jul; 3(5873):199-202. PubMed ID: 4578134
[TBL] [Abstract][Full Text] [Related]
15. Epipodophyllotoxin (VP 16-213) in the treatmetn of diffuse histiocytic lymphoma.
S Afr Med J; 1975 Mar; 49(13):483-5. PubMed ID: 167460
[TBL] [Abstract][Full Text] [Related]
16. [Results obtained with the clinical use of adriamycin].
Esposito S; Taylor LA
Haematologica; 1971; 56(9):343-66. PubMed ID: 5004536
[No Abstract] [Full Text] [Related]
17. Use of vinblastine for maintenance therapy in malignant lymphomas.
Klener P; Donner L; Ort J
Neoplasma; 1974; 21(3):323-9. PubMed ID: 4608740
[No Abstract] [Full Text] [Related]
18. Chemotherapy of lymphoma with mechlorethamine and vinblastine.
Solomon J; Jacobs EM; Bateman JR; Lukes RJ; Weiner JM; Donohue DM
Arch Intern Med; 1973 Mar; 131(3):407-17. PubMed ID: 4569376
[No Abstract] [Full Text] [Related]
19. [Results of cytostatic therapy of malignant hemoblastoses].
Stacher A
Wien Z Inn Med; 1966 Jan; 47(1):1-16. PubMed ID: 4962311
[No Abstract] [Full Text] [Related]
20. [Experiences with intense cytostatic therapy of malignant tumors].
Siering H; Reinhardt M
Arzneimittelforschung; 1968 Sep; 18(9):1182-91. PubMed ID: 4885374
[No Abstract] [Full Text] [Related]
[Next] [New Search]
